BIO|MASTER.CorSky Family Post-market Study for the CorSky Family of ICDs
NCT: NCT07360158 · RECRUITING
Brief Summary
The CorSky family is BIOTRONIK´s new generation of ICDs. They are the successor devices of the current Acticor/Rivacor family and inherit all iShock/iShock\_BC (Ilivia Neo, Intica Neo) implant and programmer software features. The new features of CorSky Family are either true novel BIOTRONIK ICD features or mainly driven by unification with the Amvia pacemaker family (Amvia Edge, -Sky). The goal of the study is to confirm the safety and performance of the CorSky Family of ICDs and CRT-Ds.
Frequently Asked Questions
What is BIO|MASTER.CorSky Family Post-market Study for the CorSky Family of ICDs?
BIO|MASTER.CorSky Family Post-market Study for the CorSky Family of ICDs is a clinical trial registered under NCT07360158. Current status: RECRUITING.
What is the status of NCT07360158?
The current status of NCT07360158 (BIO|MASTER.CorSky Family Post-market Study for the CorSky Family of ICDs) is: RECRUITING.
When did BIO|MASTER.CorSky Family Post-market Study for the CorSky Family of ICDs start?
BIO|MASTER.CorSky Family Post-market Study for the CorSky Family of ICDs started on 2026-06-22.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.